11.08.22 -- Developing Optimal Formulations Using Biorelevant Predictive Tools

This webinar provides an overview of co-amorphous research and its recent findings, particularly the impact of low molecular weight excipient on developability, stability, and solubility. Experts discuss the amorphous dispersion formulation via spray drying and hot melt extrusion.

API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability can help increase your chances of success when moving from preclinical development to early-phase clinical trials.

Together, nuclear magnetic resonance (NMR) and MS analysis can definitively identify reference standards, active pharmaceutical ingredients (APIs), or final drug product composition.

Raman spectroscopy is used to compare the dissolution rates and pellet fine structure of branded Sporanox® with three similar generic products marketed across the world, all containing the same API.